DOUBLE-BLIND, CROSSOVER PLACEBO CONTROLLED TRIAL OF SELEGILINE IN PARKINSONS-DISEASE - AN INTERIM ANALYSIS

被引：11
|
作者：
TEYCHENNE, PF
PARKER, S
机构：
[1] BALMAIN HOSP,SYDNEY,AUSTRALIA
[2] ROZELLO HOSP,SYDNEY,AUSTRALIA
[3] RECKITT & COLMAN PHARMACEUT,W RYDE,NSW,AUSTRALIA
[4] NEW S WALES INST PSYCHIAT,SYDNEY,NSW,AUSTRALIA
来源：
ACTA NEUROLOGICA SCANDINAVICA | 1989年 / 80卷
关键词：
D O I：
10.1111/j.1600-0404.1989.tb01791.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：119 / 125
页数：7
相关论文
共 50 条
  • [31] SELEGILINE AND LEVODOPA IN EARLY OR MODERATELY ADVANCED PARKINSONS-DISEASE - A DOUBLE-BLIND CONTROLLED SHORT-TERM AND LONG-TERM STUDY
    SIVERTSEN, B
    DUPONT, E
    MIKKELSEN, B
    MOGENSEN, P
    RASMUSSEN, C
    BOESEN, F
    HEINONEN, E
    ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 : 147 - 152
  • [32] Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial
    Brown, SGA
    Wiese, MD
    Blackman, KE
    Heddle, RJ
    LANCET, 2003, 361 (9362): : 1001 - 1006
  • [33] A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor
    Frima, N
    Grünewald, RA
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (02) : 94 - 96
  • [34] KETANSERIN IN REFLEX SYMPATHETIC DYSTROPHY - A DOUBLE-BLIND PLACEBO CONTROLLED CROSSOVER TRIAL
    HANNA, MH
    PEAT, SJ
    PAIN, 1989, 38 (02) : 145 - 150
  • [35] A PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSSOVER TRIAL OF FLUNARIZINE IN COMMON MIGRAINE
    SORENSEN, PS
    HANSEN, K
    OLESEN, J
    CEPHALALGIA, 1986, 6 (01) : 7 - 14
  • [36] EFFECT OF CLOMIPRAMINE ON MYOTONIA - A PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSSOVER TRIAL
    ANTONINI, G
    VICHI, R
    LEARDI, MG
    PENNISI, E
    MONZA, GC
    MILLEFIORINI, M
    NEUROLOGY, 1990, 40 (09) : 1473 - 1474
  • [37] Olanzapine in essential tremor: A double-blind, crossover, placebo-controlled trial
    Entner, T
    Wissel, J
    Mueller, J
    Seppi, K
    Wenning, GK
    Poewe, W
    MOVEMENT DISORDERS, 2002, 17 : S350 - S350
  • [38] PEN INJECTED APOMORPHINE AGAINST OFF PHENOMENA IN LATE PARKINSONS-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    OSTERGAARD, L
    WERDELIN, L
    ODIN, P
    LINDVALL, O
    DUPONT, E
    CHRISTENSEN, PB
    BOISEN, E
    JENSEN, NB
    INGWERSEN, SH
    SCHMIEGELOW, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (06): : 681 - 687
  • [39] LABETALOL, A CROSSOVER DOUBLE-BLIND CONTROLLED TRIAL
    SANDERS, GL
    ROUTLEDGE, PA
    RAO, JG
    GALES, GM
    DAVIES, DM
    RAWLINS, MD
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (05) : 301 - 304
  • [40] DIHYDROERGOCRYPTINE IN THE TREATMENT OF PARKINSONS-DISEASE - A 6 MONTHS DOUBLE-BLIND CLINICAL-TRIAL
    MARTIGNONI, E
    PACCHETTI, C
    SIBILLA, L
    BRUGGI, P
    PEDEVILLA, M
    NAPPI, G
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (01) : 78 - 83
12345